Insider Transactions Reported by 24 Insiders of Lyell Immunopharma, Inc.

Symbol
LYEL on Nasdaq
Location
South San Francisco, CA

Insiders trading volume in the past year

Lyell Immunopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
ROBERT NELSEN Director, 10%+ Owner $83,020,992 14 Jun 2024
GSK plc 10%+ Owner $68,977,271 21 Jun 2021
Hans Edgar Bishop Director $10,683,200 14 Jun 2024
Richard Klausner Director $1,791,262 +$94,942 +5.6% 15 May 2025
Lynn Seely President and CEO, Director $1,081,931 +$14,722 +1.4% 10 Nov 2025
ARCH Venture Partners IX, LLC 10%+ Owner $728,252 25 Jul 2025
ARCH Venture Fund XIII, L.P. 10%+ Owner $375,375 25 Jul 2025
Charles W. Newton Chief Financial Officer $271,186 +$93,515 +53% 20 Aug 2025
Stephen J. Hill Chief Operating Officer $253,890 -$14,047 -5.2% 10 Nov 2025
Gary K. Lee Chief Scientific Officer $248,314 -$20,335 -7.6% 10 Nov 2025
Veronica Sanchez Bulis VP, Corporate Controller $230,797 -$78,029 -25% 24 Dec 2025
CATHY FRIEDMAN Director $158,093 15 May 2025
Matthew Lang Chief Business Officer $114,000 10 Feb 2025
Sumant Ramachandra Director $94,000 +$115,220 15 May 2025
OTIS W. BRAWLEY Director $16,750 +$19,958 15 May 2025
Tina M. Albertson Chief Medical Officer $9,232 24 Feb 2023
David Shook Chief Medical Officer $8,760 09 Jun 2025
Mark A. Meltz General Counsel 09 Jun 2025
Mark Bachleda Director 09 Jun 2025
WILLIAM JL RIEFLIN Director 15 May 2025
Heather D. Turner Chief General Counsel 16 Mar 2022
Rahsaan Thompson Chief Legal Officer 24 Feb 2023
ELIZABETH G. NABEL Director 15 May 2025
Elizabeth Homans Chief Executive Officer, Director 16 Mar 2022

Recent Insider Transactions by Companies or Individuals for Lyell Immunopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.